Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v6-EN
Language English English
Date Updated 2019-10-10 2019-10-09
Drug Identification Number 00060348 00060348
Brand name 5% DEXTROSE INJECTION, USP 5% DEXTROSE INJECTION, USP
Common or Proper name 5% DEXTROSE INJECTION, USP 5% DEXTROSE INJECTION, USP
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients DEXTROSE DEXTROSE
Strength(s) 5G 5G
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 50 mL (JB0040) 50 mL (JB0040)
ATC code B05BA B05BA
ATC description I.V. SOLUTIONS I.V. SOLUTIONS
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date 2019-08-27 2019-08-27
Actual start date 2019-08-27 2019-08-27
Estimated end date 2019-10-09 2019-10-11
Actual end date 2019-10-09
Shortage status Resolved Actual shortage
Company comments
Health Canada comments